
AbnomX is a pragmatic immunoinformatics company specializing in high-performance software solutions that industrialize antibody discovery and accelerate immunotherapy development. Their flagship product, the Antibody-Extractor™ platform, offers proprietary high-speed algorithms and machine learning modules to analyze antibody sequences and repertoires, supporting phage-display and NGS-based antibody discovery. The company serves senior researchers in innovative biotech and pharmaceutical companies worldwide, providing workflow-based, scalable, and secure software that automates complex immune repertoire data analysis. AbnomX's expertise and software solutions enable efficient antibody design, humanization, and clinical research acceleration, positioning it as a trusted advisor and leader in immunoinformatics.

AbnomX is a pragmatic immunoinformatics company specializing in high-performance software solutions that industrialize antibody discovery and accelerate immunotherapy development. Their flagship product, the Antibody-Extractor™ platform, offers proprietary high-speed algorithms and machine learning modules to analyze antibody sequences and repertoires, supporting phage-display and NGS-based antibody discovery. The company serves senior researchers in innovative biotech and pharmaceutical companies worldwide, providing workflow-based, scalable, and secure software that automates complex immune repertoire data analysis. AbnomX's expertise and software solutions enable efficient antibody design, humanization, and clinical research acceleration, positioning it as a trusted advisor and leader in immunoinformatics.